Carbon monoxide releasing molecule 401 (CORM-401) modulates phase I metabolism of xenobiotics

M Walter, W Stahl, P Brenneisen, AS Reichert… - Toxicology in Vitro, 2019 - Elsevier
Next to its well-studied toxicity, carbon monoxide (CO) is recognized as a signalling
molecule in various cellular processes. Thus, CO-releasing molecules (CORMs) are of …

Application of Causal Inference Methods in the Analysis of Observational Neurosurgical Data: G-Formula and Marginal Structural Model

T Kawahara, K Shiba, A Tsuchiya - World Neurosurgery, 2022 - Elsevier
Objective When using observational data to estimate the causal effects of a treatment on
clinical outcomes, we need to adjust for confounding. In the presence of time-dependent …

Burden of cerebral hypoperfusion in patients with delayed cerebral ischemia after subarachnoid hemorrhage

H Jafri, MN Diringer, M Allen, AR Zazulia… - Journal of …, 2019 - thejns.org
OBJECTIVE Delayed cerebral ischemia (DCI) after subarachnoid hemorrhage (SAH) may
result in focal neurological deficits and cerebral infarction, believed to result from critical …

Sanguinate: History and Clinical Evaluation of a Multimodal HBOCs

BT Romito, JW Romito, A Abuchowski - Blood Substitutes and Oxygen …, 2022 - Springer
Sanguinate is a unique polyethylene glycol modified form of bovine hemoglobin that
represents the latest generation of hemoglobin-based oxygen carriers. Its structural …

Blood, Blood Components, Plasma, and Plasma Products

K Sobolewski, S Radparvar, C Wong… - Side Effects of Drugs …, 2018 - Elsevier
This review of 2017 publications identifies side effects of blood, blood components, and
covers plasma products. Additionally, albumin, blood transfusion (erythrocytes …

Clinical Trials of Low‐Dose Carbon Monoxide

E Gomperts, A Gompertsd… - Carbon Monoxide in Drug …, 2022 - Wiley Online Library
The assessment of low‐dose carbon monoxide (CO) as a therapeutic in the clinic is unique
because of the diversity of data of the effects of low‐dose CO in humans. This chapter …

HEMERA‐1 CarboxyHEMoglobin OxygEn Delivery for Evascularization in Acute Stroke: A Prospective, Randomized Phase 1 Clinical Trial

I Linfante, W Clark, DC Houssen, R Hanel… - Stroke: Vascular and …, 2023 - Am Heart Assoc
BACKGROUND PP‐007 is a polyethylene glycol (PEG) ylated bovine carboxyhemoglobin
gas transfer molecule with pleotropic cytoprotective effects, vasodilatation, plasma …

[HTML][HTML] When blood transfusion is not an option owing to religious beliefs

EP Crowe, RA DeSimone - Annals of Blood, 2022 - aob.amegroups.org
Patients who decline blood transfusion on the basis of religious belief, such as Jehovah's
Witnesses, pose unique management dilemmas and opportunities for healthcare. In …

Hemoglobin-Based Oxygen Carriers: Brief History, Pharmacology and Design Strategies, Review of the Major Products in Clinical Trials, On-Going Studies, and …

JS Jahr, K Roghani, Y Buqa, A Rojhani, P Jhita… - Blood Substitutes and …, 2022 - Springer
Transfusion of erythrocytes (RBC) to treat acute or chronic anemia has significant
drawbacks, given the risks of transfusion, volunteer donor requirements, limited supply with …

Neuroprotection for acute brain ischaemia

N Sanossian, JL Saver - Stroke prevention and treatment: an …, 2020 - books.google.com
Normally, cerebral blood flow (CBF) is maintained by cerebral autoregulation at about 50 mL
blood/100 g brain/min. In acute ischaemic stroke, a cerebral artery is occluded or there is a …